{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:47:15Z","timestamp":1769636835638,"version":"3.49.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008131","name":"Rheinische Friedrich-Wilhelms-Universit\u00e4t Bonn","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008131","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    While genome-wide association studies (GWAS) have linked common genetic variants to COVID-19 susceptibility and severity, rare high-impact variants may also contribute to phenotypic heterogeneity. Inborn errors of type I interferon immunity (IFN-I-IEIs), including X-linked\n                    <jats:italic>TLR7<\/jats:italic>\n                    deficiency, account for\u2009~\u20092% of critical COVID-19 cases. In this study, we investigated rare potentially deleterious variants in IFN-I-IEI and GWAS-prioritized genes in young, severely affected COVID-19 patients from the German National Pandemic Cohort Network (NAPKON). Genome sequencing was performed on 110 hospitalized COVID-19 patients, including 82 males and 28 females, all under 60\u00a0years of age and without relevant pre-existing medical conditions. Rare potentially deleterious variants in\n                    <jats:italic>TLR7<\/jats:italic>\n                    and 25 additional IFN-I-IEI genes, as well as 23 GWAS risk genes for COVID-19 severity, were analyzed based on allele frequency, predicted functional impact, and inheritance pattern models and subsequently classified based on the American College of Medical Genetics and Genomics (ACMG) criteria. Polygenic Risk Scores (PRS) were additionally calculated as an exploratory and case-only analysis to assess the contribution of common variant-derived genetic predisposition for severe COVID-19. Consistent with prior findings from other studies in German cohorts, no candidate variants or large deletions were identified in\n                    <jats:italic>TLR7<\/jats:italic>\n                    . However, 7 variants of uncertain significance in IFN-I-IEI genes as well as 13 candidate variants of potential deleterious effect in GWAS risk genes were present in 19 individuals (17.3%). We observed nominally significant differences in PRS distributions, with younger individuals (&lt;\u200940\u00a0years) having higher PRS (p\u2009=\u20090.045) compared to older individuals, and carriers of rare variants having lower PRS compared to non-carriers (p\u2009=\u20090.037). These patterns are consistent with an age-dependent contribution of polygenic risk to severe COVID-19 and a potentially lower polygenic burden among rare-variant carriers, although confirmation in larger well-controlled cohorts will be required. The candidate variants identified in IFN-I-IEI and GWAS risk genes represent targets for further functional studies to clarify their potential contribution to disease risk. These findings highlight the need for future integrative genomic approaches to better understand the joint contribution of common and rare variants to COVID-19 severity.\n                  <\/jats:p>","DOI":"10.1186\/s40246-025-00904-9","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T15:55:12Z","timestamp":1769183712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic contribution to severe COVID-19 in adults under 60\u00a0years without major comorbidities in the German National Pandemic Cohort Network (NAPKON)"],"prefix":"10.1186","volume":"20","author":[{"given":"Ayda","family":"Abolhassani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Madhusankha","family":"Alawathurage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura L.","family":"Kilarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siri","family":"G\u00f6pel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Hanses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes Christian","family":"Hellmuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Herr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achim J.","family":"Kaasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Kobbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarethe Justine","family":"Konik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabell","family":"Pink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"R\u00f6mmele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian S.","family":"Scheer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Stellbrink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Christian","family":"Stubbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil-Robin","family":"Tepasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Teufel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Vad\u00e1sz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J. G. T.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Witzenrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Anton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Br\u00f6hl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Herold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Illig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffi","family":"Jiru-Hillmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Krawitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lazar","family":"Mitrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Philipsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina M.","family":"P\u00fctz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus M.","family":"Noethen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Nuernberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens-Peter","family":"Reese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Riess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Schultze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fridolin","family":"Steinbeis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Janne","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Wildberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin U.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva C.","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"904_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533\u20134.","journal-title":"Lancet Infect Dis"},{"key":"904_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003346","volume":"17","author":"D Buitrago-Garcia","year":"2020","unstructured":"Buitrago-Garcia D, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 2020;17:e1003346.","journal-title":"PLoS Med"},{"key":"904_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41586-020-2918-0","volume":"590","author":"M O\u2019Driscoll","year":"2021","unstructured":"O\u2019Driscoll M, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590:140\u20135.","journal-title":"Nature"},{"key":"904_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.16901","volume":"4","author":"TD Bennett","year":"2021","unstructured":"Bennett TD, et al. Clinical characterization and prediction of clinical severity of SARS-CoV-2 infection among US adults using data from the US national COVID cohort collaborative. JAMA Netw Open. 2021;4:e2116901.","journal-title":"JAMA Netw Open"},{"key":"904_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","volume":"588","author":"T Takahashi","year":"2020","unstructured":"Takahashi T, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588:315\u201320.","journal-title":"Nature"},{"key":"904_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430\u20136.","journal-title":"Nature"},{"key":"904_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","volume":"94","author":"J Yang","year":"2020","unstructured":"Yang J, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91\u20135.","journal-title":"Int J Infect Dis"},{"key":"904_CR8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2200413119","volume":"119","author":"J Manry","year":"2022","unstructured":"Manry J, et al. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. Proc Natl Acad Sci U S A. 2022;119:e2200413119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"904_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41576-022-00478-5","volume":"23","author":"MEK Niemi","year":"2022","unstructured":"Niemi MEK, Daly MJ, Ganna A. The human genetic epidemiology of COVID-19. Nat Rev Genet. 2022;23:533\u201346.","journal-title":"Nat Rev Genet"},{"key":"904_CR10","doi-asserted-by":"crossref","unstructured":"Severe Covid-19 GWAS Group et al. Genomewide association study of severe covid-19 with respiratory failure. N Engl J Med. 2020;383:1522\u20131534.","DOI":"10.1056\/NEJMoa2020283"},{"key":"904_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41586-021-03767-x","volume":"600","author":"COVID-19 Host Genetics Initiative","year":"2021","unstructured":"COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature. 2021;600:472\u20137.","journal-title":"Nature"},{"key":"904_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","volume":"591","author":"E Pairo-Castineira","year":"2021","unstructured":"Pairo-Castineira E, et al. Genetic mechanisms of critical illness in COVID-19. Nature. 2021;591:92\u20138.","journal-title":"Nature"},{"key":"904_CR13","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/s41586-022-04826-7","volume":"608","author":"COVID-19 Host Genetics Initiative","year":"2022","unstructured":"COVID-19 Host Genetics Initiative. A first update on mapping the human genetic architecture of COVID-19. Nature. 2022;608:E1\u201310.","journal-title":"Nature"},{"key":"904_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41586-022-04576-6","volume":"607","author":"A Kousathanas","year":"2022","unstructured":"Kousathanas A, et al. Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature. 2022;607:97\u2013103.","journal-title":"Nature"},{"key":"904_CR15","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41586-023-06034-3","volume":"617","author":"E Pairo-Castineira","year":"2023","unstructured":"Pairo-Castineira E, et al. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature. 2023;617:764\u20138.","journal-title":"Nature"},{"key":"904_CR16","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1038\/s41586-023-06355-3","volume":"621","author":"COVID-19 Host Genetics Initiative","year":"2023","unstructured":"COVID-19 Host Genetics Initiative. A second update on mapping the human genetic architecture of COVID-19. Nature. 2023;621:E7\u201326.","journal-title":"Nature"},{"key":"904_CR17","unstructured":"Zhang Q et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:eabd4570."},{"key":"904_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13073-023-01173-8","volume":"15","author":"D Matuozzo","year":"2023","unstructured":"Matuozzo D, et al. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. Genome Med. 2023;15:22.","journal-title":"Genome Med"},{"key":"904_CR19","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/jama.2020.13719","volume":"324","author":"CI van der Made","year":"2020","unstructured":"van der Made CI, et al. Presence of Genetic Variants Among Young Men With Severe COVID-19. JAMA. 2020;324:663\u201373.","journal-title":"JAMA"},{"key":"904_CR20","unstructured":"Asano T et al. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci Immunol. 2021;6:eabl4348."},{"key":"904_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010367","volume":"18","author":"G Butler-Laporte","year":"2022","unstructured":"Butler-Laporte G, et al. Exome-wide association study to identify rare variants influencing COVID-19 outcomes: results from the Host Genetics Initiative. PLoS Genet. 2022;18:e1010367.","journal-title":"PLoS Genet"},{"key":"904_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01075","volume":"8","author":"C Petes","year":"2017","unstructured":"Petes C, Odoardi N, Gee K. The toll for trafficking: toll-like receptor 7 delivery to the endosome. Front Immunol. 2017;8:1075.","journal-title":"Front Immunol"},{"key":"904_CR23","volume":"5","author":"J Boos","year":"2024","unstructured":"Boos J, et al. Stratified analyses refine association between TLR7 rare variants and severe COVID-19. HGG Adv. 2024;5:100323.","journal-title":"HGG Adv"},{"key":"904_CR24","unstructured":"Bastard P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585."},{"key":"904_CR25","unstructured":"Bastard P et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021;6:eabl4340."},{"key":"904_CR26","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231353","volume":"221","author":"P Bastard","year":"2024","unstructured":"Bastard P, et al. Higher COVID-19 pneumonia risk associated with anti-IFN-\u03b1 than with anti-IFN-\u03c9 auto-Abs in children. J Exp Med. 2024;221:e20231353.","journal-title":"J Exp Med"},{"key":"904_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41586-022-04447-0","volume":"603","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Bastard P, COVID Human Genetic Effort, Cobat A, Casanova J-L. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. 2022;603:587\u201398.","journal-title":"Nature"},{"key":"904_CR28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210554","volume":"218","author":"P Bastard","year":"2021","unstructured":"Bastard P, et al. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. J Exp Med. 2021;218:e20210554.","journal-title":"J Exp Med"},{"key":"904_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jaci.2021.03.034","volume":"148","author":"A Lemarquis","year":"2021","unstructured":"Lemarquis A, et al. Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis. J Allergy Clin Immunol. 2021;148:96\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"904_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10875-022-01245-1","volume":"42","author":"L Schidlowski","year":"2022","unstructured":"Schidlowski L, Iwamura APD, COVID-SUD, Condino-Neto A, Prando C. Diagnosis of APS-1 in two siblings following life-threatening COVID-19 pneumonia. J Clin Immunol. 2022;42:749\u201352.","journal-title":"J Clin Immunol"},{"key":"904_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012786","volume":"20","author":"A Schmidt","year":"2024","unstructured":"Schmidt A, et al. Systematic assessment of COVID-19 host genetics using whole genome sequencing data. PLoS Pathog. 2024;20:e1012786.","journal-title":"PLoS Pathog"},{"key":"904_CR32","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2020.05.016","volume":"181","author":"J-L Casanova","year":"2020","unstructured":"Casanova J-L, Su HC, COVID Human Genetic Effort. A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection. Cell. 2020;181:1194\u20139.","journal-title":"Cell"},{"key":"904_CR33","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10654-022-00896-z","volume":"37","author":"M Schons","year":"2022","unstructured":"Schons M, et al. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics. Eur J Epidemiol. 2022;37:849\u201370.","journal-title":"Eur J Epidemiol"},{"key":"904_CR34","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","volume":"20","author":"WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection","year":"2020","unstructured":"WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20:e192\u20137.","journal-title":"Lancet Infect Dis"},{"key":"904_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559\u201375.","journal-title":"Am J Hum Genet"},{"key":"904_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1101\/gr.246934.118","volume":"30","author":"F Zhang","year":"2020","unstructured":"Zhang F, et al. Ancestry-agnostic estimation of DNA sample contamination from sequence reads. Genome Res. 2020;30:185\u201394.","journal-title":"Genome Res"},{"key":"904_CR37","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","volume":"26","author":"A Manichaikul","year":"2010","unstructured":"Manichaikul A, et al. Robust relationship inference in genome-wide association studies. Bioinformatics. 2010;26:2867\u201373.","journal-title":"Bioinformatics"},{"key":"904_CR38","doi-asserted-by":"crossref","unstructured":"1000 Genomes Project Consortium et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374.","DOI":"10.1038\/nature15393"},{"key":"904_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09718-5","volume":"10","author":"T Ge","year":"2019","unstructured":"Ge T, Chen C-Y, Ni Y, Feng Y-CA, Smoller JW. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat Commun. 2019;10:1776.","journal-title":"Nat Commun"},{"key":"904_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17:122.","journal-title":"Genome Biol"},{"key":"904_CR41","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310\u20135.","journal-title":"Nat Genet"},{"key":"904_CR42","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99:877\u201385.","journal-title":"Am J Hum Genet"},{"key":"904_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7492","volume":"381","author":"J Cheng","year":"2023","unstructured":"Cheng J, et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science. 2023;381:eadg7492.","journal-title":"Science"},{"key":"904_CR44","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343.","journal-title":"Nature"},{"key":"904_CR45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176:535-548.e24.","journal-title":"Cell"},{"key":"904_CR46","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41588-023-01608-3","volume":"56","author":"MH Guo","year":"2024","unstructured":"Guo MH, et al. Inferring compound heterozygosity from large-scale exome sequencing data. Nat Genet. 2024;56:152\u201361.","journal-title":"Nat Genet"},{"key":"904_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24\u20136.","journal-title":"Nat Biotechnol"},{"key":"904_CR48","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"904_CR49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI166283","volume":"133","author":"J-L Casanova","year":"2023","unstructured":"Casanova J-L, Anderson MS. Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs. J Clin Invest. 2023;133:e166283.","journal-title":"J Clin Invest"},{"key":"904_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101531","volume":"12","author":"J Wang","year":"2025","unstructured":"Wang J, et al. Clinical relevance of loss-of-function mutations of NEMO\/IKBKG. Genes Dis. 2025;12:101531.","journal-title":"Genes Dis"},{"key":"904_CR51","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.immuni.2015.04.021","volume":"42","author":"BE Oftedal","year":"2015","unstructured":"Oftedal BE, et al. Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. Immunity. 2015;42:1185\u201396.","journal-title":"Immunity"},{"key":"904_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106818","volume":"26","author":"BE Oftedal","year":"2023","unstructured":"Oftedal BE, et al. Dominant-negative heterozygous mutations in AIRE confer diverse autoimmune phenotypes. iScience. 2023;26:106818.","journal-title":"iScience"},{"key":"904_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08026-8","volume":"10","author":"TG Schips","year":"2019","unstructured":"Schips TG, et al. Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability. Nat Commun. 2019;10:76.","journal-title":"Nat Commun"},{"key":"904_CR54","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.ajhg.2021.05.017","volume":"108","author":"JA Kosmicki","year":"2021","unstructured":"Kosmicki JA, et al. Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals. Am J Hum Genet. 2021;108:1350\u20135.","journal-title":"Am J Hum Genet"},{"key":"904_CR55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI147834","volume":"131","author":"G Povysil","year":"2021","unstructured":"Povysil G, et al. Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19. J Clin Invest. 2021;131:e147834.","journal-title":"J Clin Invest"},{"key":"904_CR56","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1093\/hmg\/11.20.2371","volume":"11","author":"A Smahi","year":"2002","unstructured":"Smahi A. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet. 2002;11:2371\u20135.","journal-title":"Hum Mol Genet"},{"key":"904_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13373","volume":"100","author":"R Najm","year":"2024","unstructured":"Najm R, et al. IFIH1 loss of function predisposes to inflammatory and SARS\u2010CoV \u20102\u2010related infectious diseases. Scand J Immunol. 2024;100:e13373.","journal-title":"Scand J Immunol"},{"key":"904_CR58","doi-asserted-by":"publisher","first-page":"394632025135113","DOI":"10.1177\/03946320251351138","volume":"39","author":"L Xie","year":"2025","unstructured":"Xie L, Hu X, Wang H, Feng J, He R. A new heterozygous TYK2 gene mutation: case report and review of the literature. Int J Immunopathol Pharmacol. 2025;39:3946320251351138.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"904_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113689","volume":"43","author":"Y Mao","year":"2024","unstructured":"Mao Y, et al. Deep spatial proteomics reveals region-specific features of severe COVID-19-related pulmonary injury. Cell Rep. 2024;43:113689.","journal-title":"Cell Rep"},{"key":"904_CR60","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00439-021-02397-7","volume":"141","author":"C Fallerini","year":"2022","unstructured":"Fallerini C, et al. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity. Hum Genet. 2022;141:147\u201373.","journal-title":"Hum Genet"},{"key":"904_CR61","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev-biodatasci-020222-021705","volume":"6","author":"A Cobat","year":"2023","unstructured":"Cobat A, et al. Human genomics of COVID-19 pneumonia: contributions of rare and common variants. Annu Rev Biomed Data Sci. 2023;6:465\u201386.","journal-title":"Annu Rev Biomed Data Sci"},{"key":"904_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11112-0","volume":"10","author":"L Duncan","year":"2019","unstructured":"Duncan L, et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nat Commun. 2019;10:3328.","journal-title":"Nat Commun"},{"key":"904_CR63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ajhg.2021.11.008","volume":"109","author":"F Priv\u00e9","year":"2022","unstructured":"Priv\u00e9 F, et al. Portability of 245 polygenic scores when derived from the UK Biobank and applied to 9 ancestry groups from the same cohort. Am J Hum Genet. 2022;109:12\u201323.","journal-title":"Am J Hum Genet"},{"key":"904_CR64","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152386","volume":"131","author":"T Nakanishi","year":"2021","unstructured":"Nakanishi T, et al. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. J Clin Invest. 2021;131:e152386.","journal-title":"J Clin Invest"},{"key":"904_CR65","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1093\/hmg\/ddac158","volume":"31","author":"F Degenhardt","year":"2022","unstructured":"Degenhardt F, et al. Detailed stratified GWAS analysis for severe COVID-19 in four European populations. Hum Mol Genet. 2022;31:3945\u201366.","journal-title":"Hum Mol Genet"},{"key":"904_CR66","doi-asserted-by":"publisher","unstructured":"Lee DSM et al. Common- and rare-variant genetic architecture of heart failure across the allele frequency spectrum. medRxiv. 2024. 2023.07.16.23292724. https:\/\/doi.org\/10.1101\/2023.07.16.23292724.","DOI":"10.1101\/2023.07.16.23292724"},{"key":"904_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43878-9","volume":"14","author":"A Khan","year":"2023","unstructured":"Khan A, et al. Polygenic risk alters the penetrance of monogenic kidney disease. Nat Commun. 2023;14:8318.","journal-title":"Nat Commun"},{"key":"904_CR68","doi-asserted-by":"publisher","unstructured":"Smail C. et al. Complex trait associations in rare diseases and impacts on Mendelian variant interpretation. medRxiv 2024.01.10.24301111. 2024. https:\/\/doi.org\/10.1101\/2024.01.10.24301111.","DOI":"10.1101\/2024.01.10.24301111"},{"key":"904_CR69","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41586-024-08217-y","volume":"636","author":"QQ Huang","year":"2024","unstructured":"Huang QQ, et al. Examining the role of common variants in rare neurodevelopmental conditions. Nature. 2024;636:404\u201311.","journal-title":"Nature"},{"key":"904_CR70","doi-asserted-by":"publisher","unstructured":"Williams J, et al. Integrating common and rare variants improves polygenic risk prediction across diverse populations. Preprint at. 2024. https:\/\/doi.org\/10.1101\/2024.11.05.24316779.","DOI":"10.1101\/2024.11.05.24316779"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-025-00904-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00904-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00904-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T09:04:22Z","timestamp":1769591062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40246-025-00904-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["904"],"URL":"https:\/\/doi.org\/10.1186\/s40246-025-00904-9","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SH reports consulting fees from AstraZeneca (Vaxzevria Vaccine Program Advisory Board) and Janssen (RSV Vaccine Program Advisory Board).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}